This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Methods and Results A total of 323 consecutive FAT patients who underwent electrophysiological study and radiofrequency catheter ablation between January 2011 and March 2023 were selected for this study. Conclusion Significant age differences were observed in the distribution of FAT foci.
With the unveiling of the Genesis System, Baptist Health Lexington has become the first in Kentucky, and one of the first in the world, to provide the latest advancement in robotic technology to treat cardiac arrhythmias. “We In 2006, Lewis realized something was not right with his heart during one of his regular outdoor runs.
the most commonly overlooked arrhythmia ( See My Comment at the bottom of the page in the May 1, 2023 — and the November 12, 2019 post , among others ). Why was it Wrong to Think the Rhythm was AFlutter? I have emphasized on many occasions in Dr. Smith's ECG Blog how AFlutter is by far (!)
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
billion in 2023, warranting a better understanding of the mechanisms involved in HF. Among the most serious manifestations associated with HF is arrhythmia due to the electrophysiological changes within the cardiomyocyte. The total cost of care for HF is USD 69.8
The most common arrhythmia, atrial fibrillation , will affect approximately 12.1 Food and Drug Administration (FDA) in July 2023, a new leadless pacemaker system placed in both chambers of the heart and using a novel communication technology is now offering a more minimally invasive option for patients. Approved by the U.S.
In the past decade, major advances were made in catheter ablation for arrhythmias and implantation of cardiac implantable electronic devices.1 1 Catheter ablation for atrial fibrillation (AF) and ventricular tachycardia (VT) has become the standard of care for many patients presenting with these arrhythmias.2–4
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The acquisition of Laminar, Inc.
The international Working Group of the Signal Summit is a consortium of experts in the field of cardiac electrophysiology dedicated to advancing knowledge on understanding and clinical application of signal recording and processing techniques.
This could be easily overlooked since there is complete heart block, but recognizing the atrial arrhythmia may mean prescribing anticoagulation to prevent stroke. The September 15, 2023 post — for PTA ( Pulse-Tap Artifact ). The March 17, 2023 post — for PTA. The January 17, 2023 post — for PTA.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
Procedural data and electrophysiology (EP) laboratory times were systematically collected and analyzed. Upper limit skin-to-skin time and missed FPI resulted predictors of the primary endpoint.ConclusionThis standardized workflow resulted in low procedural times and arrhythmias recurrence without compromising the safety.
ABSTRACT Objectives Activation mapping for idiopathic ventricular arrhythmias (IVAs) typically relies on identifying the earliest bipolar electrograms and unipolar electrograms characterized by an initial QS morphology preceding the intrinsic deflection.
Ambulatory electrocardiography (ECG) lets in for prolonged tracking of arrhythmias in an actual-global setting. KEY POINTS Ambulatory ECG tracking is generally used to correlate signs with arrhythmia, verify occult atrial fibrillation, and determine the efficacy of antiarrhythmic therapy.
Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012191, November 1, 2023. Atrioventricular AP (true AP) were distinguished from fasciculoventricular fibers (FVF) using standard invasive electrophysiology study criteria. Preexcitation was exclusively FVF mediated in 8 (36%) patients.
Important Deadlines: Early registration fee: January 9, 2023. Late registration fee: February 8, 2023. Important Deadlines: Abstract and late-breaking clinical trial submission is closed (Deadline: December 7 and October 17, 2023) Fees: Visit the ACC 2024 website for registration options. Hashtag: #ACVC2024 2. Hashtag: #ACC24 3.
Circulation: Arrhythmia and Electrophysiology, Volume 16, Issue 11 , Page e012043, November 1, 2023. Prospectively defined secondary end points included repeat ablations, unscheduled arrhythmia-related visits, and quality of life among groups.RESULTS:Of 200 PersAF patients, 98 were assigned to ADT OFF and 102 to ADT ON.
Since the patient was stable and tolerating the arrhythmia it was decided to treat with IV Amiodarone for medical conversion. This electrophysiological property is called decremental conduction. Definite treatment is in the electrophysiology lab where ablation of the accessory pathway can be performed. 2023, January 31).
milla1cf Tue, 12/26/2023 - 21:19 December 26, 2023 — Pulse Biosciences, Inc. , Patients will continue to be monitored and evaluated over the coming months to assess safety and effectiveness with the primary safety endpoint at 30 days.
Image courtesy: Peerbridge Health christine.book Tue, 12/19/2023 - 10:22 December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% David's Medical Center.
Getty Images milla1cf Fri, 12/08/2023 - 08:17 December 8, 2023 — The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib). This is a complex disease.
ABSTRACT Background Atrial fibrillation (AF) is the most common arrhythmia worldwide. Methods We included adult patients who had an index admission with AF to Latakia's tertiary center between July 2021 and November 2023. This study assessed the rate, predictors, and trends of 6-month readmission after index admission for AF in Syria.
The review is based on a presentation by the senior author during the 2023 16th annual European Cardiac Arrhythmia Society (ECAS) congress in Paris, France.
88% of patients in the Tailored cohort experienced freedom from AF 12 months after one procedure with or without anti-arrhythmic drugs compared to 70% in the Anatomical cohort (log rank p In the Tailored cohort, patients experienced a higher rate of freedom from any arrhythmia after 1.2 adult population. adult population.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. 2013.05.063 3 [link] [last accessed June 9, 2023] If you enjoy this content, please share it with a colleague
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.
2023 ) Falling on EP’s shoulder That was enough for me to make a compelling call to my EP colleague, for a quick chat about this unique patient. Massie Block -Ref 1) But, if there is something unusual in the clinical history, be ready to investigate until the arrhythmia, or at least the anxiety disappears. J Clin Med. ROTONDI, F.,
Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001. EP Europace, Volume 25, Issue 5, May 2023, euad061. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Remote monitoring offers an effective and safe method for monitoring patients with cardiovascular implantable electronic devices. The downside of remote monitoring is the overflow of the data.
Brugada Syndrome: Diagnosis and Risk Stratification Hello friends, this is the modified version of my talk at Indian Heart Rhythm Society Conference, New Delhi, 2023, on Brugada Syndrome. This is the proposed mechanism of precipitation of arrhythmias in Brugada syndrome during febrile episodes. Hope you will enjoy this session.
Prior to Mizusawa's study, it was thought that the incidence of syncope, arrhythmia, or SCD in this cohort was low [7]. In light of the risk of arrhythmia events observed in the Mizusawa trial, a formal EP study might be reasonable to obtain in those with fever induced asymptomatic Brugada ECG changes to help risk stratify these patients.
Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD). J Am Coll Cardiol.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. We aimed to assess their respective performances in an independent cohort.METHODS:All patients with HCM aged <18 years from a single center were retrospectively included between 2003 and 2023. males), with a mean follow-up of 8.65.5
Distinction is made between: ERP ( E arly R epolarization " P attern" ) in which the ECG findings of early repolarization are seen in the absence of symptomatic arrhythmias. The CHALLENGE: In 2008 Hassaguerre found an increased prevalence of ER in patients with idiopathic VFib ( N Engl J Med 358:2016-2023, 2008 ).
For right or wrong reasons, the world of electrophysiology has pushed us into a belief system that, if it is AF, the culprit must be pulmonary veins. Focus-less Atrial fibrillation Right from the days of James Mckenzie , when AF was refered to as delirium cordis or ataxia of pulse, AF was always considered as a chaotic, focus-less arrhythmia.
The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath. "The
Methods and Results Between January 2020 and December 2023, 118 PeAF patients were selected for first intent Marshall plan ablation (MPA). Marshall vein failure occurred in 9/118 patients (7.6%). Accordingly, 109 patients who underwent MPA as first-line therapy were included.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content